Related Experiment Video
Updated: Aug 19, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[New therapeutic options in renal diseases--hypotensive therapy]
1Katedra i Klinika Chor6b Wewnetrznych, Nadciśnienia Tetniczego i Angiologii AM w Warszawie.
Abstract:
Progression of a variety of chronic renal diseases may be largely due to secondary hemodynamic and metabolic factors, rather than the activity of the underlying disorder. Some of these factors can be treated, possibly preventing or minimizing further glomerular injury. An important component of this approach is antihypertensive therapy, particularly with angiotensin converting enzyme (ACE) inhibitors and, at least in patients with type 2 diabetes, angiotensin II receptor blockers. The clinical studies supporting importance of blood pressure control in diabetic and nondiabetic chronic renal diseases and recommended treatment goals will be presented here.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
